Smart Pharmaceutical Formulation and Drug Delivery Using AI

Abstract

Artificial intelligence and machine learning are transforming pharmaceutical formulation and drug delivery by shifting traditional trial-and-error approaches towards data-driven, predictive methodologies. This study examines the potential of AI to enhance drug development efficiency, optimise formulation design, and address significant pharmaceutical challenges such as elevated development costs, inadequate drug solubility, and intricate formulation variables. Artificial intelligence techniques, including support vector machines, deep learning models, and artificial neural networks, facilitate the rapid analysis of large datasets to predict critical quality attributes such as stability, bioavailability, and drug release profiles. AI integration in pre-formulation studies diminishes experimental workload and accelerates decision-making by facilitating accurate predictions of physicochemical properties. AI-assisted compatibility analysis and excipient selection also make formulations work better and last longer. Self-emulsifying drug delivery systems, nanomedicine, and controlled-release formulations are advanced uses that show how AI can make treatments work better. AI also cuts down on the time and money needed for traditional methods of drug discovery, target identification, and virtual screening by a large amount. AI-driven methods are more efficient, repeatable, and scalable than human-generated formulations, but issues with data quality, regulatory acceptance, and model interpretability still exist. AI also helps with managing the lifecycle, predicting stability, and optimising drug delivery systems. This makes products better and lowers the number of failures. The combination of AI with digital prototyping and Design of Experiments helps intelligent manufacturing and formulation innovation even more. Despite these drawbacks, hybrid approaches that combine human knowledge with AI capabilities hold the key to the future of pharmaceutical sciences. All things considered, AI-driven formulation techniques have enormous potential to transform pharmaceutical research by increasing precision, shortening development times, and improving patient outcomes.